When stroke drug developer Argenica Therapeutics (ASX:AGN) revisited the results of its recent phase II trial, it turned to a ...
Clinical trials are well-controlled and designed experiments that aim to prove that an Investigational Medicinal Product (IMP) is effective. Clinical trial data is submitted to the national health ...